XML 45 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Business Segment and Geographical Information (Tables)
 12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
(In millions)
 
2015

 
2014

 
2013

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
4,439.4

 
$
4,195.7

 
$
712.5

Analytical Instruments
 
3,208.2

 
3,252.2

 
3,154.2

Specialty Diagnostics
 
3,243.9

 
3,343.6

 
3,191.7

Laboratory Products and Services
 
6,661.5

 
6,601.5

 
6,398.8

Eliminations
 
(587.6
)
 
(503.4
)
 
(366.9
)
 
 
 
 
 
 
 
Consolidated revenues
 
16,965.4

 
16,889.6

 
13,090.3

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,336.9

 
1,214.9

 
169.7

Analytical Instruments
 
612.8

 
581.1

 
558.7

Specialty Diagnostics
 
872.9

 
916.0

 
863.7

Laboratory Products and Services
 
999.1

 
982.8

 
960.4

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
3,821.7

 
3,694.8

 
2,552.5

 
 
 
 
 
 
 
Cost of revenues charges
 
(9.1
)
 
(327.6
)
 
(28.6
)
Selling, general and administrative charges, net
 
(46.3
)
 
(130.7
)
 
(73.5
)
Restructuring and other (costs) income, net
 
(115.3
)
 
598.2

 
(77.7
)
Amortization of acquisition-related intangible assets
 
(1,314.8
)
 
(1,331.7
)
 
(763.1
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,336.2

 
2,503.0

 
1,609.6

Other expense, net (b)
 
(399.8
)
 
(415.8
)
 
(290.1
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
1,936.4

 
$
2,087.2

 
$
1,319.5

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
146.3

 
$
131.6

 
$
17.1

Analytical Instruments
 
38.9

 
39.0

 
41.2

Specialty Diagnostics
 
73.7

 
76.7

 
73.9

Laboratory Products and Services
 
114.5

 
105.8

 
104.6

 
 
 
 
 
 
 
Consolidated depreciation
 
$
373.4

 
$
353.1

 
$
236.8

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
(In millions)
 
2015

 
2014

 
2013

 
 
 
 
 
 
 
Total Assets
 
 
 
 
 
 
Life Sciences Solutions
 
$
17,884.3

 
$
19,257.0

 
$
1,115.5

Analytical Instruments
 
4,763.1

 
4,133.3

 
4,321.4

Specialty Diagnostics
 
7,183.2

 
8,047.7

 
9,086.0

Laboratory Products and Services
 
10,266.6

 
10,875.7

 
11,523.5

Corporate/Other (c)
 
791.8

 
538.4

 
5,817.0

 
 
 
 
 
 
 
Consolidated total assets
 
$
40,889.0

 
$
42,852.1

 
$
31,863.4

 
 
 
 
 
 
 
Capital Expenditures
 
 
 
 
 
 
Life Sciences Solutions
 
$
85.1

 
$
104.4

 
$
19.3

Analytical Instruments
 
59.5

 
38.1

 
33.5

Specialty Diagnostics
 
75.9

 
84.7

 
77.9

Laboratory Products and Services
 
97.7

 
102.1

 
94.7

Corporate/Other
 
104.7

 
98.3

 
57.0

 
 
 
 
 
 
 
Consolidated capital expenditures
 
$
422.9

 
$
427.6

 
$
282.4

(c)
Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices and assets of the discontinued operations.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
(In millions)
 
2015

 
2014

 
2013

 
 
 
 
 
 
 
Revenues
 
 
 
 
 
 
Life Sciences Solutions
 
$
4,439.4

 
$
4,195.7

 
$
712.5

Analytical Instruments
 
3,208.2

 
3,252.2

 
3,154.2

Specialty Diagnostics
 
3,243.9

 
3,343.6

 
3,191.7

Laboratory Products and Services
 
6,661.5

 
6,601.5

 
6,398.8

Eliminations
 
(587.6
)
 
(503.4
)
 
(366.9
)
 
 
 
 
 
 
 
Consolidated revenues
 
16,965.4

 
16,889.6

 
13,090.3

 
 
 
 
 
 
 
Segment Income (a)
 
 
 
 
 
 
Life Sciences Solutions
 
1,336.9

 
1,214.9

 
169.7

Analytical Instruments
 
612.8

 
581.1

 
558.7

Specialty Diagnostics
 
872.9

 
916.0

 
863.7

Laboratory Products and Services
 
999.1

 
982.8

 
960.4

 
 
 
 
 
 
 
Subtotal reportable segments (a)
 
3,821.7

 
3,694.8

 
2,552.5

 
 
 
 
 
 
 
Cost of revenues charges
 
(9.1
)
 
(327.6
)
 
(28.6
)
Selling, general and administrative charges, net
 
(46.3
)
 
(130.7
)
 
(73.5
)
Restructuring and other (costs) income, net
 
(115.3
)
 
598.2

 
(77.7
)
Amortization of acquisition-related intangible assets
 
(1,314.8
)
 
(1,331.7
)
 
(763.1
)
 
 
 
 
 
 
 
Consolidated operating income
 
2,336.2

 
2,503.0

 
1,609.6

Other expense, net (b)
 
(399.8
)
 
(415.8
)
 
(290.1
)
 
 
 
 
 
 
 
Income from continuing operations before income taxes
 
$
1,936.4

 
$
2,087.2

 
$
1,319.5

 
 
 
 
 
 
 
Depreciation
 
 
 
 
 
 
Life Sciences Solutions
 
$
146.3

 
$
131.6

 
$
17.1

Analytical Instruments
 
38.9

 
39.0

 
41.2

Specialty Diagnostics
 
73.7

 
76.7

 
73.9

Laboratory Products and Services
 
114.5

 
105.8

 
104.6

 
 
 
 
 
 
 
Consolidated depreciation
 
$
373.4

 
$
353.1

 
$
236.8

(a)
Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.
(b)
The company does not allocate other expense, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
(In millions)
 
2015

 
2014

 
2013

 
 
 
 
 
 
 
Revenues (d)
 
 
 
 
 
 
United States
 
$
8,607.3

 
$
8,147.7

 
$
6,617.0

China
 
1,376.4

 
1,223.1

 
896.6

Germany
 
899.7

 
1,005.9

 
758.6

United Kingdom
 
778.1

 
754.5

 
532.4

Other
 
5,303.9

 
5,758.4

 
4,285.7

 
 
 
 
 
 
 
Consolidated revenues
 
$
16,965.4

 
$
16,889.6

 
$
13,090.3

 
 
 
 
 
 
 
Long-lived Assets (e)
 
 
 
 
 
 
United States
 
$
1,532.0

 
$
1,501.7

 
$
892.9

United Kingdom
 
261.1

 
265.5

 
224.3

Germany
 
169.4

 
170.3

 
165.9

Other
 
486.3

 
489.0

 
484.3

 
 
 
 
 
 
 
Consolidated long-lived assets
 
$
2,448.8

 
$
2,426.5

 
$
1,767.4

(d)
Revenues are attributed to countries based on customer location.
(e)
Includes property, plant and equipment, net